HIV reverse transcriptase inhibitors
US8354421B2 · kind B2 · utility
6Cited by
25References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 26, 2008 |
| Grant date | Jan 15, 2013 |
| Priority date | — |
| Expiry date | Aug 19, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/18
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention is related to compounds of Formula (I):or a pharmaceutically acceptable salt, solvate, ester, and/or phosphonate thereof, compositions containing such compounds, and therapeutic methods that include the administration of such compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.